256 filings
Page 4 of 13
8-K
kv73er
8 Nov 21
Matinas BioPharma Reports Third Quarter 2021 Financial Results and Operational Highlights
6:35am
8-K
i1wmry50r
1 Nov 21
Submission of Matters to a Vote of Security Holders
5:15pm
8-K
p86 g1c5ol
20 Sep 21
Matinas BioPharma Announces Accomplished Biotechnology Executive and Drug Developer Kathryn Penkus Corzo as Nominee to the Board of Directors
7:05am
8-K
z5vzv7z8gap uv6l
13 Sep 21
Regulation FD Disclosure
6:05am
8-K
2lz4ewe4qw4a33yu8vg3
10 Aug 21
Matinas BioPharma Reports Second Quarter 2021 Financial Results and Operational Highlights
6:35am
8-K
pxldo 6pibbh
10 May 21
Matinas BioPharma Reports First Quarter 2021 Financial Results and Operational Highlights
6:35am
8-K
dgbn7zcz jmzdf0c
29 Mar 21
Matinas BioPharma Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Highlights
6:35am
S-8
in1ei h04k
26 Feb 21
Registration of securities for employees
5:26pm
8-K
x77edt0hkjn7 u0yg
1 Feb 21
Regulation FD Disclosure
6:03am
8-K
idqa dhjy
27 Jan 21
Submission of Matters to a Vote of Security Holders
5:28pm
8-K
0uc0gd
14 Jan 21
Regulation FD Disclosure
7:00am
8-K
5oefxnsrg27
28 Dec 20
Other Events
6:07am
8-K
d4pd fclsxl
8 Dec 20
Regulation FD Disclosure
12:00am
8-K
yjr5kyk9
1 Dec 20
Matinas BioPharma Appoints Hui Liu, Ph.D., M.B.A. as Chief Technology Officer
5:05pm